Your browser doesn't support javascript.
loading
ERBB3 Overexpression is Enriched in Diverse Patient Populations with Castration-sensitive Prostate Cancer and is Associated with a Unique AR Activity Signature.
Vellky, Jordan E; Kirkpatrick, Brenna J; Gutgesell, Lisa C; Morales, Mathias; Brown, Ryan M; Wu, Yaqi; Maienschein-Cline, Mark; Notardonato, Lucia D; Weinfeld, Michael S; Nguyen, Ryan H; Brister, Eileen; Sverdlov, Maria; Liu, Li; Xu, Ziqiao; Kregel, Steven; Nonn, Larisa; Vander Griend, Donald J; Reizine, Natalie M.
Affiliation
  • Vellky JE; Department of Pathology, The University of Illinois at Chicago, Chicago, Illinois.
  • Kirkpatrick BJ; The University of Illinois Cancer Center, Chicago, Illinois.
  • Gutgesell LC; Department of Pathology, The University of Illinois at Chicago, Chicago, Illinois.
  • Morales M; Department of Pathology, The University of Illinois at Chicago, Chicago, Illinois.
  • Brown RM; Department of Pathology, The University of Illinois at Chicago, Chicago, Illinois.
  • Wu Y; Department of Pathology, The University of Illinois at Chicago, Chicago, Illinois.
  • Maienschein-Cline M; Department of Pathology, The University of Illinois at Chicago, Chicago, Illinois.
  • Notardonato LD; Research Informatics Core, Research Resources Center, The University of Illinois at Chicago, Chicago, Illinois.
  • Weinfeld MS; UI Health Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
  • Nguyen RH; UI Health Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
  • Brister E; UI Health Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
  • Sverdlov M; Research Tissue Imaging Core, Department of Pathology, The University of Illinois at Chicago, Chicago, Illinois.
  • Liu L; Research Histology Core, Research Resource Center, The University of Illinois at Chicago, Chicago, Illinois.
  • Xu Z; The University of Illinois Cancer Center, Chicago, Illinois.
  • Kregel S; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, Illinois.
  • Nonn L; The University of Illinois Cancer Center, Chicago, Illinois.
  • Vander Griend DJ; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, Illinois.
  • Reizine NM; Department of Cancer Biology, Loyola University Chicago, Chicago, Illinois.
Clin Cancer Res ; 30(8): 1530-1543, 2024 Apr 15.
Article in En | MEDLINE | ID: mdl-38306015
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Benzamides / Prostatic Neoplasms, Castration-Resistant Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2024 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylthiohydantoin / Benzamides / Prostatic Neoplasms, Castration-Resistant Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2024 Document type: Article Country of publication: Estados Unidos